CVR 33026013Public limited company (A/S)Engroshandel med medicinalvarer og sygeplejeartikler (464610)FredensborgFounded 1 Feb 1971
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about VELIN-PHARMA A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexGross profit
95K
DKK, annual report 2025
Result
-16M
DKK, annual report 2025
Equity
33.5M
DKK, annual report 2025
Thomas Velin25% to under 33.3% of capital and votes, since 1 Feb 1971
Charlotte Velin25% to under 33.3% of capital and votes, since 1 Feb 1971
and 2 moreOperating company
Dandex estimate: revenue or gross profit in the 2025 reportFlemming Velinsince 1 Feb 1971
15% to under 20% of capital and votesnotified 15 Dec 2002since 1 Feb 1971
15% to under 20% of capital and votesnotified 15 Dec 2002since 1 Feb 1971
25% to under 33.3% of capital and votesnotified 15 Dec 2002since 1 Feb 1971
25% to under 33.3% of capital and votesnotified 15 Dec 2002since 1 Feb 1971
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
VELIN-PHARMA A/S holds no Danish company now.
Found by searching the CVR owner register (ejerregister) for VELIN-PHARMA A/S as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 27913547100% of capital and votes17 Jun 2004 to 10 Jun 2021
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
1 Feb 1971 to 13 Nov 2026.
1 Feb 1971 to 13 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 150 | 440 | 161 | -3 | 95 |
| Result for the year | +5,954 | +3,117 | +5,547 | +12,695 | -16,021 |
| Equity | 28,124 | 31,241 | 36,789 | 49,484 | 33,463 |
| Total assets | 29,882 | 32,076 | 38,448 | 52,976 | 36,757 |
| Employees (average) | 0 | 0 | 0 | 0 | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -46.1% | 193% | -63.3% | -102.1% | n.m.note 1 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
1 Jun 2024 to 31 May 2025, published 28 Nov 2025
Annual report 2024
1 Jun 2023 to 31 May 2024, published 6 Nov 2024
Annual report 2023
1 Jun 2022 to 31 May 2023, published 28 Nov 2023
Annual report 2022
1 Jun 2021 to 31 May 2022, published 9 Dec 2022
Annual report 2021
1 Jun 2020 to 31 May 2021, published 29 Oct 2021
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For VELIN-PHARMA A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 13 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 13 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
11 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Bestyrelse:
Fratrådte:
Niels Ebbe Valdal, den 27.09.2024, Thomas Velin, den 27.09.2024.
Tiltrådte:
Thomas Velin, (formand), den 27.09.2024.
Revision:
Fratrådte:
GLB REVISION, STATSAUTORISEREDE REVISORER A/S, den 16.08.2021.
Tiltrådte:
CVR-NR. 32895468 BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, Fændediget 13, 4600 Køge, den 16.08.2021.
Ved kommunalreformen den 1. januar 2007 er hjemstedskommunen ændret.
Revision:
Udtrådt af revisionen:
Statsaut. revisor Iver H. Iversen, den 22.03.2006.
Indtrådt i revisionen:
CVR-NR. 25164792 GYRN LOPS BRANDT STATSAUTORISEREDE REVISORER A/S, Fændediget 13, 4600 Køge, den 22.03.2006.
Vedtægter ændret:
04.09.2000.
Nyt navn:
VELIN-PHARMA A/S.
Nyt binavn: JOHANNES LARSENS EFTF., V. OG F. VELIN A/S (VELIN-PHARMA A/S).
Bestyrelse:
Udtrådt af bestyrelsen:
Indtrådt i bestyrelsen:
Fru Majken Velin.
Direktion:
Udtrådt af direktionen:
Vedtægter ændret:
12.12.1990
Ny adresse:
Kongevejen 66, 3480 Fredensborg
Ny kommune:
Fredensborg-Humlebæk
REG.NR. A/S46595
NAVN: JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S
ADRESSE: Gl. Kongevej 99, 1850 Fred.berg C
Stiftelsesdato:
01.02.1971
Seneste vedtægtsdato:
23.10.1975
Kapital:
kr. 700.000,00
Indbetalingsmåde:
kontant/i værdier kr. 700.000,00 til kurs 100,0
Bestyrelse:
Advokat Niels Ebbe Valdal, Møbelhandler Flemming Velin, Direktør Viggo Gunnar Velin
Direktion:
Møbelhandler Flemming Velin, Direktør Viggo Gunnar Velin
Selskabet tegnes af en direktør alene eller
af den samlede bestyrelse
Revision:
Statsaut. revisor Iver Hansen Iversen, 2000 Frederiksberg
Første regnskabsår:
00.00 - 00.00
Regnskabsår:
01.06 - 31.05
Selskabets navn forkert konverteret. Skal være: JOHANNES LARSENS EFTF., V. OG F. VELIN A/S.
2 registered in CVR.
P-number 100650288766, 9999 Ukendt
P-number 1001698976Kongevejen 66, 3480 Fredensborg